NeuroOne Secures ISO 13485 Certification, Unlocking International Revenue Path
NMTC is trading near its 52-week low of $1.423 (9.6% above the low) on elevated volume (2.1× avg).
Summary
NeuroOne received ISO 13485 certification, a critical quality management standard for medical devices. This allows the company to pursue international sales of its Evo electrodes and OneRF ablation system, with near-term revenue potential. The certification comes after a restatement and going concern warning in June, making new revenue streams especially important. The company plans to work with distribution partner Zimmer Biomet and explore independent distributors for markets it controls directly.
At the time of this announcement, NMTC was trading at $1.56 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $13.6M. The 52-week trading range was $1.42 to $6.96. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: EQS.